INSYS Therapeutics To Present At 37th Annual J.P. Morgan Healthcare Conference

On January 3, 2019 INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, reported that Saeed Motahari, president and chief executive officer, and Andy Long, chief financial officer, will present at the J.P. Morgan Healthcare Conference as follows (Press release, Insys Therapeutics, JAN 3, 2019, View Source [SID1234532401]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!


Date: Thursday, January 10th, 2019
Time: 10:30 a.m. Pacific Standard Time
Location: Westin St. Francis Hotel, San Francisco, California

The presentation will be webcast live at the above-mentioned time, and archived for 30 days thereafter, via the Investors section of company’s website at View Source, under Presentations & Events. Accessible at the same webpage, the presentation slides will be available during and after the conference.